NEW YORK (360Dx) – Genetic Signatures today said that it has received regulatory approvals in Australia and Europe for separate enteric products.

Australia's Therapeutic Goods Administration has approved the firm's Enteric Viral Detection product. Additionally, its EasyScreen Enteric Pathogen Detection Kit range received CE-IVD marking.

The company had previously secured regulatory approval for its Enteric Protozoan, Enteric Bacterial, and C. difficile detection products, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.